| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aad15cdfb05597c84c73889ea0703b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1767 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate |
2019-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39e95bf0f2213b82a9a20f6d6b3bfc21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2280298356c28c156cc11c2d3f001304
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cbcca7e556e9ef97fc27dc3dbf61eb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ee86a6de7a1634ba114f4fe7130abdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e03aff260b76ba9eb07248b38d015338
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21d32da0cca5558dbbb8179253f7bafa |
| publicationDate |
2019-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-3089358-A1 |
| titleOfInvention |
Anticoagulant proteins and their use for treating diseases associated with the activation of neutrophils |
| abstract |
The present invention relates to a protein or polypeptide comprising an Ixodes ricinus salivary gland polypeptide, a fragment or a variant thereof, and its use for inhibiting the extrinsic coagulation pathway and for treating and/or preventing diseases and conditions associated to the recruitment and activation of neutrophils following activation of the extrinsic coagulation pathway. In particular, the present invention relates to the use of a protein comprising an Ixodes ricinus salivary gland polypeptide, a fragment or a variant thereof, for the treatment and/or prevention of any thrombotic events associated with the recruitment and activation of neutrophils following activation of the extrinsic coagulation pathway. |
| priorityDate |
2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |